AEP
59
-3
VLO
42
2
AAP
26
2
TGNA
64
2
MKC
42
-2
ADI
59
2
BBY
51
2
RF
54
4
MTB
53
4
NFLX
61
-3
UNP
55
6
SYY
50
-2
CMG
34
3
DG
28
-6
ALLE
39
4
AKAM
53
3
A
24
-3
CL
70
-4
HBI
59
3
HPE
59
2
AEP
59
-3
VLO
42
2
AAP
26
2
TGNA
64
2
MKC
42
-2
ADI
59
2
BBY
51
2
RF
54
4
MTB
53
4
NFLX
61
-3
UNP
55
6
SYY
50
-2
CMG
34
3
DG
28
-6
ALLE
39
4
AKAM
53
3
A
24
-3
CL
70
-4
HBI
59
3
HPE
59
2
Financhill
Back

Trinity Biotech PLC 10K Form

Sell
32

TRIB
Trinity Biotech PLC

Last Price:
2.14
Seasonality Move:
-10.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRIB News And Ratings

See the #1 stock for the next 7 days that we like better than TRIB

TRIB Financial Statistics

Sales & Book Value

Annual Sales: $56.83M
Cash Flow: $-4.28M
Price / Cash Flow: 0
Annual Sales: $-2.41
Price / Book: 0

Profitability

EPS (TTM): -23.49500
Net Income (TTM): $-21.53M
Gross Margin: $19.45M
Return on Equity: 0%
Return on Assets: -28.59%

Trinity Biotech PLC Earnings Forecast

Key Trinity Biotech PLC Financial Ratios

  • The Gross Profit Margin over the past 30 years for TRIB is 34.22%.
  • The Selling, General & Administrative Expenses for TRIB have been equal to 54.81% of Gross Profit Margin.
  • The Research & Development expenses have been 7.71% of Revenue.
  • The Interest Expense is -42.25% of Operating Income.
  • The Net Earning history of TRIB is -42.26% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 15 years.

Trinity Biotech PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TRIB
CUSIP: 896438
Website: trinitybiotech.com

Debt

Debt-to-Equity Ratio: -3.22
Current Ratio: 2.02
Quick Ratio: 1.03

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRIB Technical Analysis vs Fundamental Analysis

Sell
32
Trinity Biotech PLC (TRIB) is a Sell

Is Trinity Biotech PLC a Buy or a Sell?